Advanced Heart Failure and Transplant Cardiology · Evanston, IL
NPI
1417974973
Since 2006
Specialty
Advanced Heart Failure and Transplant Cardiology
Code 207RA0001X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
1000 Central St Ste 730
Evanston, IL, 60201
Phone (847) 663-8410
Groups this clinician bills Medicare through
Medicare paid, 2024
$156K
1,849 services
Medicare patients, 2024
592
Average age 78
Drug cost, 2024
$7.9M
9,363 prescriptions
Company payments, 2025
$6,087
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Robert A Gordon was code 99233 (hospital e&m - subsequent), 524 times for 136 patients. In total Robert A Gordon billed 1,849 services in 31 codes, and Medicare paid $156K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-12-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 524 | 136 | $96.52 | $51K |
| 99215 Office E&M - Established | Facility | 250 | 213 | $105.33 | $26K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 149 | 143 | $13.47 | $2,007 |
| 99214 Office E&M - Established | Facility | 122 | 114 | $70.81 | $8,639 |
| 93010 Electrocardiogram | Facility | 120 | 116 | $6.13 | $736 |
| 99291 Critical Care E&M | Facility | 102 | 39 | $176.86 | $18K |
| 99215 Office E&M - Established | Office | 95 | 81 | $137.84 | $13K |
| 99223 Hospital E&M - Initial | Facility | 77 | 69 | $137.88 | $11K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 75 | 64 | $13.29 | $997 |
| 99214 Office E&M - Established | Office | 53 | 45 | $98.58 | $5,225 |
| 94621 Pulmonary Function Testing | Facility | 48 | 48 | $53.55 | $2,570 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 39 | 22 | $25.69 | $1,002 |
| 99205 Office E&M - New | Office | 29 | 29 | $183.75 | $5,329 |
| 93000 Electrocardiogram | Office | 27 | 27 | $11.92 | $322 |
| 99205 Office E&M - New | Facility | 20 | 20 | $143.40 | $2,868 |
By year: 2022 $152K for 1,610 services; 2023 $157K for 1,582 services; 2024 $156K for 1,849 services.
Medicare prescription drug claims, 2024
In 2024, the drug Robert A Gordon prescribed most often to Medicare patients was Spironolactone, with 852 prescriptions and refills. In total Robert A Gordon wrote 9,363 Medicare prescriptions that cost $7.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Spironolactone Generic | 852 | 2,248 | 267 | $7,598 |
| Entresto Sacubitril/Valsartan | 824 | 1,799 | 219 | $1.1M |
| Atorvastatin Calcium Generic | 704 | 1,954 | 235 | $7,804 |
| Metoprolol Succinate Generic | 598 | 1,522 | 181 | $8,722 |
| Farxiga Dapagliflozin Propanediol | 489 | 1,022 | 122 | $554K |
| Jardiance Empagliflozin | 447 | 965 | 117 | $540K |
| Carvedilol Generic | 429 | 1,202 | 141 | $4,465 |
| Furosemide Generic | 427 | 1,084 | 147 | $2,394 |
| Ezetimibe Generic | 424 | 1,117 | 131 | $15K |
| Eliquis Apixaban | 391 | 962 | 129 | $547K |
| Digoxin Generic | 322 | 816 | 94 | $4,634 |
| Rosuvastatin Calcium Generic | 236 | 622 | 76 | $5,275 |
| Clopidogrel Clopidogrel Bisulfate | 202 | 534 | 66 | $2,471 |
| Bumetanide Generic | 200 | 514 | 74 | $6,885 |
| Ozempic Semaglutide | 194 | 324 | 54 | $291K |
Brand drugs: 3,303 claims; generic drugs: 6,060 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Robert A Gordon $6,087 ($6,087 in general payments such as food, travel and fees) from 16 companies. The largest payer was E.R. Squibb & Sons, L.L.C. with $5,002.
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. BMY | 11 | $5,002 |
| Novartis Pharmaceuticals Corporation NVS | 13 | $322 |
| CVRx, Inc. CVRX | 5 | $262 |
| Abbott Laboratories ABT | 4 | $85.27 |
| Edwards Lifesciences Corporation EW | 1 | $83.68 |
| BridgeBio Pharma, Inc. BBIO | 2 | $66.95 |
| Medtronic, Inc. MDT | 1 | $63.89 |
| Pfizer Inc. PFE | 1 | $39.79 |
| Boston Scientific Corporation BSX | 1 | $28.48 |
| Alnylam Pharmaceuticals Inc. ALNY | 1 | $27.99 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.